Results 301 to 310 of about 13,388,670 (413)

Critical Care Nursing Workforce Retention From an Irish Perspective: A National Survey. [PDF]

Nurs Crit Care
McEvoy NL, Credland N, Cribbin D, Curley GF, Humphries N.   +4 more
europepmc   +1 more source

Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017

Intensive Care Medicine, 2018
D. Annane, S. Pastores, B. Rochwerg, W. Arlt, R. Balk, A. Beishuizen, J. Briegel, J. Carcillo, M. Christ-Crain, M. Cooper, P. Marik, G. Umberto Meduri, K. Olsen, Sophia Rodgers, J. Russell, G. Van den Berghe   +15 more
semanticscholar   +1 more source

Critical Care

Psychoanalytic Dialogues, 2020
openaire   +1 more source

Glycosylation Gene Signatures as Prognostic Biomarkers in Glioblastoma

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Glioblastoma (GBM) is an aggressive brain tumor characterized by significant heterogeneity. This study investigates the role of glycosylation‐related genes in GBM subtyping, prognosis, and response to therapy. Methods We analyzed mRNA expression data and clinical information from The Cancer Genome Atlas (TCGA) and Gene Expression ...
Tong Zhao, Hongliang Ge, Chenchao Lin, Xiyue Wu, Jianwu Chen   +4 more
wiley   +1 more source

Siloed thinking: The case for integrating economic and environmental analysis in critical care. [PDF]

Crit Care Resusc
Collins M, Higgins L, McAlister S, McGain F.   +3 more
europepmc   +1 more source

Myostatin Levels in SMA Following Disease‐Modifying Treatments: A Multi‐Center Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study investigated myostatin levels in SMA patients receiving disease‐modifying therapies (DMTs) to understand their relationship with treatment duration and functional status. Methods Our study includes both cross‐sectional and longitudinal analyses of myostatin levels in treated SMA patients.
Fiorella Piemonte, Sara Petrillo, Anna Capasso, Giorgia Coratti, Adele D'Amico, Michela Catteruccia, Maria Carmela Pera, Concetta Palermo, Marika Pane, Emanuela Abiusi, Gianpaolo Cicala, Marianna Villa, Chiara Bravetti, Chiara Arpaia, Agnese Novelli, Salvatore Falqui, Stefania Fiori, Giulia Napoli, Silvia Baroni, Francesco Danilo Tiziano, Enrico Bertini, Giacomo Comi, Stefania Corti, Eugenio Mercuri   +23 more
wiley   +1 more source

Prehospital transfusion training in Canada: a national survey of critical care transport organizations. [PDF]

Scand J Trauma Resusc Emerg Med
Dion PM, Pan A, Beckett A, Singh K, Greene A, Benhamed A, McGowan M, Nolan B.   +7 more
europepmc   +1 more source

Critical Care Meets Hospice Care

, 1994
Deborah J. Golder
openalex   +1 more source

Critical care outcomes [PDF]

Anaesthesia, 2001
openaire   +3 more sources

CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive complaints without objective cognitive impairment in Parkinson's Disease, termed Parkinson's Disease‐Subjective Cognitive Decline (PD‐SCD), have been associated with cognitive decline. However, its progression is heterogeneous, highlighting the need for improved identification of patients at greater risk for deterioration ...
Jon Rodriguez‐Antiguedad, Arnau Puig‐Davi, Iñigo Ruíz‐Barrio, Javier Pagonabarraga, Anna Vázquez‐Oliver, Andrea Horta‐Barba, Jaime Kulisevsky, Saül Martínez‐Horta   +7 more
wiley   +1 more source